Skip to content

The multi center controlled clinical trial of porcine skin acellular matrix and porcine pericardium acellular matrix to repair inguinal hernia

The multi center controlled clinical trial of porcine skin acellular matrix and porcine pericardium acellular matrix to repair inguinal hernia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-16009010
Enrollment
Unknown
Registered
2016-08-11
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inguinal hernia

Interventions

Control group:repair inguinal hernia by porcine pericardium acellular matrix
Treatment group:repair inguinal hernia by porcine skin acellular matrix

Sponsors

Shanghai ninth people's hospital,Bethune International Peace Hospital of PLA,The Second Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. hospitalized patient signed informed consent; 2. aged 18-75 years and not be ready for having baby in one year after surgery; 3. one side primary henias; 4. accept elective surgery.

Exclusion criteria

Exclusion criteria: 1. yonger than 18 or older than 75 years patient; 2. participated in other clinical trials in the beginning 3 months; 3. liver dysfunction and kidney dysfunction(1.5 times higher than normal test results); 4. significant hematologic abnormalities(anemia: lower than normal;fever:temperature higher than 37 degree C; bleeding; internal bleeding and external bleeding); 5. brain disorders, or can not cope with the researcher because of brain disorders,judge disabnormal and mental problem; 6. heart disease(class II and class IIIabove cardiac insufficiency); 7. suffering from severs metabolic diseases,cndocrine diseases(drugs can not control persons) 8. serve lung disease asthma,lung function disorders; 9. impaired immune function; 10. pregnancy and breast-feeding women; 11. other surgical contraindications.

Design outcomes

Primary

MeasureTime frame
recurrence;

Secondary

MeasureTime frame
pain;Complications;

Countries

China

Contacts

Public ContactYan Gu

Shanghai ninth people's hospital, Shanghai jiaotong university school of medicine

yangu@shsmu.edu.cn+86 13661756660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026